rVSV-EBOV
Merck and NewLink Ebola vaccine trial begins
March 6, 2015Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
